Abbott Laboratories
ABT
$109.58
$0.960.88%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.83% | -39.36% | 8.03% | -7.59% | 34.26% |
| Total Depreciation and Amortization | 32.00% | 1.39% | 0.13% | 1.80% | 2.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -47.00% | 78.09% | 48.33% | -15.49% | -50.87% |
| Change in Net Operating Assets | 137.64% | -255.01% | 145.26% | 135.64% | 31.69% |
| Cash from Operations | 89.20% | -60.33% | 18.95% | 36.15% | 44.46% |
| Capital Expenditure | -24.56% | 42.09% | -38.91% | 1.20% | -3.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 99.17% | -98,890.00% | 63.64% | -83.33% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 90.55% | 37.75% | -317.02% | 288.00% | -457.14% |
| Cash from Investing | 96.69% | -2,126.07% | -99.78% | 21.48% | -23.83% |
| Total Debt Issued | -99.84% | 994,450.00% | -- | -100.00% | 100.00% |
| Total Debt Repaid | 0.78% | -1,866.67% | 85.40% | -2,800.00% | 98.36% |
| Issuance of Common Stock | -97.41% | 2,220.00% | -92.75% | 97.14% | -87.80% |
| Repurchase of Common Stock | -480.56% | 40.40% | 0.98% | -4,983.33% | 97.86% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.36% | -6.60% | 0.10% | -0.19% | -0.29% |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -120.32% | 1,339.30% | 20.63% | -60.44% | 46.62% |
| Foreign Exchange rate Adjustments | 117.39% | -483.33% | 160.00% | -119.61% | 112.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.16% | -270.03% | 80.54% | 33.65% | 138.65% |